Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Moderate Alzheimer's Disease Treated With Donepezil.
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2016
At a glance
- Drugs Idalopirdine (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms LADDER
- 11 Apr 2016 Results will be presented at the 2016 American Academy of Neurology (AAN) Annual Meeting, according to a Lundbeck Inc media release.
- 16 Jul 2013 Results presented at the 2013 Alzheimer's Association International Conference .
- 16 Jul 2013 Results will be published in Alzheimer's and Dementia: The Journal of the Alzheimer's Association, according to a media release from Lundbeck and Otsuka.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History